Gene · 406949
Papers3,765
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
561 to 580 of 3,765
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| The AGMK1-9T7 cell model of neoplasia: Evolution of DNA copy-number aberrations and miRNA expression during transition from normal to metastatic cancer cells. | PLoS One | 2022 | 36279283 | PubTator, text mining | PubMed |
| Whole-transcriptome sequencing and ceRNA interaction network of temporomandibular joint osteoarthritis. | Front Genet | 2022 | 36276964 | PubTator, text mining | PubMed |
| Identification of Differentially Expressed microRNAs Associated with Ischemic Stroke by Integrated Bioinformatics Approaches. | Int J Genomics | 2022 | 36262825 | PubTator, text mining | PubMed |
| Study of KRAS-Related miRNA Expression in Colorectal Cancer. | Cancer Manag Res | 2022 | 36262749 | PubTator, text mining | PubMed |
| Therapeutic Potential of miRNAs for Type 2 Diabetes Mellitus: An Overview. | Epigenet Insights | 2022 | 36262691 | PubTator, text mining | PubMed |
| Angiogenesis and Its Targeting in Glioblastoma with Focus on Clinical Approaches. | Cell J | 2022 | 36259473 | PubTator, text mining | PubMed |
| Exosomes derived from bone marrow mesenchymal stem cells inhibit human aortic vascular smooth muscle cells calcification via the miR-15a/15b/16/NFATc3/OCN axis. | Biochem Biophys Res Commun | 2022 | 36257194 | PubTator, text mining | PubMed |
| Pleiotropic effects of DCLK1 in cancer and cancer stem cells. | Front Mol Biosci | 2022 | 36250024 | PubTator, text mining | PubMed |
| miR-aculous new avenues for cancer immunotherapy. | Front Immunol | 2022 | 36248881 | PubTator, text mining | PubMed |
| Ginsenoside Rg1 Inhibits STAT3 Expression by miR-15b-5p to Attenuate Lung Injury in Mice with Type 2 Diabetes Mellitus-Associated Pulmonary Tuberculosis. | Evid Based Complement Alternat Med | 2022 | 36248428 | PubTator, text mining | PubMed |
| TIMELESS is a key gene mediating thrombogenesis in COVID-19 and antiphospholipid syndrome. | Sci Rep | 2022 | 36241659 | PubTator, text mining | PubMed |
| Identification of Candidate MicroRNA-mRNA Subnetwork for Predicting the Osteosarcoma Progression by Bioinformatics Analysis. | Comput Math Methods Med | 2022 | 36238488 | PubTator, text mining | PubMed |
| Predicting miRNA-disease associations based on multi-view information fusion. | Front Genet | 2022 | 36238163 | PubTator, text mining | PubMed |
| Overview of MicroRNAs as Diagnostic and Prognostic Biomarkers for High-Incidence Cancers in 2021. | Int J Mol Sci | 2022 | 36232692 | PubTator, text mining | PubMed |
| Current Landscape of Therapeutic Resistance in Lung Cancer and Promising Strategies to Overcome Resistance. | Cancers (Basel) | 2022 | 36230484 | PubTator, text mining | PubMed |
| Notch-associated lncRNAs profiling circuiting epigenetic modification in colorectal cancer. | Cancer Cell Int | 2022 | 36229883 | PubTator, text mining | PubMed |
| N6-methyladenosine-related microRNAs risk model trumps the isocitrate dehydrogenase mutation status as a predictive biomarker for the prognosis and immunotherapy in lower grade gliomas. | Explor Target Antitumor Ther | 2022 | 36226036 | PubTator, text mining | PubMed |
| Current understanding of epigenetics role in melanoma treatment and resistance. | Cancer Cell Int | 2022 | 36224606 | PubTator, text mining | PubMed |
| Involvement of host microRNAs in flavivirus-induced neuropathology: An update. | J Biosci | 2022 | 36222134 | PubTator, text mining | PubMed |
| Differential expression of miRNAs in bronchoalveolar lavage fluid and plasma from patients with chronic obstructive pulmonary disease. | Medicine (Baltimore) | 2022 | 36221429 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/406949/papers?page=29